(Q35985436)

11 August 2017

1 reference

title

Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine (English)

1 reference

11 August 2017

1 reference

1 reference

McKellar QA

1

1 reference

PubMed ID

15601444

11 August 2017

Sanchez Bruni SF

series ordinal

2

1 reference

PubMed ID

15601444

11 August 2017

Jones DG

series ordinal

3

1 reference

11 August 2017

1 December 2004

1 reference

Journal of Veterinary Pharmacology and Therapeutics

11 August 2017

1 reference

11 August 2017

27

1 reference

11 August 2017

6

1 reference

11 August 2017

503-514

1 reference

Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Efficacy of beta-lactam antibiotics: integration of pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Effect of probenecid on disposition kinetics of ampicillin in horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Factors Influencing the Therapy of Experimental Proteus mirabilis Meningitis in Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

Pharmacokinetics and milk discard times of pirlimycin after intramammary infusion: a population approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2004.00603.X

10.1111/J.1365-2885.2004.00603.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15601444